Anti-PMEL/ D12S53E/ ME20 monoclonal antibody

Anti-PMEL/ D12S53E/ ME20 antibody for FACS & in-vivo assay

Target products collectionGo to PMEL/PMEL products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-T46208-Ab-1/ GM-Tg-hg-T46208-Ab-2Anti-Human PMEL monoclonal antibodyHuman
GM-Tg-rg-T46208-Ab-1/ GM-Tg-rg-T46208-Ab-2Anti-Rat PMEL monoclonal antibodyRat
GM-Tg-mg-T46208-Ab-1/ GM-Tg-mg-T46208-Ab-2Anti-Mouse PMEL monoclonal antibodyMouse
GM-Tg-cynog-T46208-Ab-1/ GM-Tg-cynog-T46208-Ab-2Anti-Cynomolgus/ Rhesus macaque PMEL monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-T46208-Ab-1/ GM-Tg-felg-T46208-Ab-2Anti-Feline PMEL monoclonal antibodyFeline
GM-Tg-cang-T46208-Ab-1/ GM-Tg-cang-T46208-Ab-2Anti-Canine PMEL monoclonal antibodyCanine
GM-Tg-bovg-T46208-Ab-1/ GM-Tg-bovg-T46208-Ab-2Anti-Bovine PMEL monoclonal antibodyBovine
GM-Tg-equg-T46208-Ab-1/ GM-Tg-equg-T46208-Ab-2Anti-Equine PMEL monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-T46208-Ab-1/ GM-Tg-hg-T46208-Ab-2; GM-Tg-rg-T46208-Ab-1/ GM-Tg-rg-T46208-Ab-2;
GM-Tg-mg-T46208-Ab-1/ GM-Tg-mg-T46208-Ab-2; GM-Tg-cynog-T46208-Ab-1/ GM-Tg-cynog-T46208-Ab-2;
GM-Tg-felg-T46208-Ab-1/ GM-Tg-felg-T46208-Ab-2; GM-Tg-cang-T46208-Ab-1/ GM-Tg-cang-T46208-Ab-2;
GM-Tg-bovg-T46208-Ab-1/ GM-Tg-bovg-T46208-Ab-2; GM-Tg-equg-T46208-Ab-1/ GM-Tg-equg-T46208-Ab-2
Products NameAnti-PMEL monoclonal antibody
Formatmab
Target NamePMEL
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-PMEL benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species PMEL/ D12S53E/ ME20 VLP (virus-like particle) (Products Developing)
    ORF Viral VectorpGMLPm005276mouse Pmel Lentivirus plasmid
    ORF Viral VectorvGMLPm005276mouse Pmel Lentivirus particle


    Target information

    Target IDGM-T46208
    Target NamePMEL
    Gene ID6490,20431,362818,710921,481102,101092774,281487,100033885
    Gene Symbol and SynonymsD10H12S53E,D12S53E,D12S53Eh,gp100,gp87,HMB-45,HMB45,ME20,ME20-M,ME20M,P1,P100,PMEL,PMEL17,RPE1,SI,SIL,SILV
    Uniprot AccessionP40967,Q06154
    Uniprot Entry NamePMEL_HUMAN,PMEL_BOVIN
    Protein Sub-locationTransmembrane Protein
    Category
    DiseaseCancer
    Gene EnsemblENSG00000185664
    Target ClassificationTumor-associated antigen (TAA)

    The target: PMEL, gene name: PMEL, also named as D12S53E, ME20, ME20-M, ME20M, P1, P10017, SI, SIL, SILV, gp100, PMEL. This gene encodes a melanocyte-specific type I transmembrane glycoprotein. The encoded protein is enriched in melanosomes, which are the melanin-producing organelles in melanocytes, and plays an essential role in the structural organization of premelanosomes. This protein is involved in generating internal matrix fibers that define the transition from Stage I to Stage II melanosomes. This protein undergoes a complex pattern of prosttranslational processing and modification that is essential to the proper functioning of the protein. A secreted form of this protein that is released by proteolytic ectodomain shedding may be used as a melanoma-specific serum marker. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Jan 2011].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.